← Back to Analyst Consensus 
MYGN Hold
MYRIAD GENETICS INC
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 4, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Oct 2, 2026 | Craig-Hallum | maintain | Buy → Buy | — | 54% |
| Sep 9, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Sep 1, 2026 | Piper Sandler | downgrade | Overweight → Underweight | — | 54% |
| Aug 18, 2026 | Stephens & Co. | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Aug 3, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 31, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| May 6, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| May 6, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Feb 24, 2026 | UBS | maintain | Neutral → Neutral | $6 | 54% |
| Feb 24, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $6 | 54% |
| Nov 11, 2025 | Piper Sandler | maintain | Overweight → Overweight | $8.5 | 54% |
| Nov 5, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $6.5 | 54% |
| Nov 4, 2025 | TD Cowen | maintain | Hold → Hold | $9 | 54% |
| Nov 4, 2025 | UBS | maintain | Neutral → Neutral | $8 | 54% |
| May 21, 2025 | Scotiabank | downgrade | Sector Outperform → Sector Perform | $6 | 55% |
| May 15, 2025 | Piper Sandler | maintain | Overweight → Overweight | $9 | 54% |
| May 8, 2025 | Wells Fargo | downgrade | Overweight → Equal-Weight | $6 | 54% |
| May 7, 2025 | Goldman Sachs | maintain | Buy → Buy | $8 | 54% |
| May 7, 2025 | UBS | maintain | Neutral → Neutral | $7 | 54% |
| May 7, 2025 | Raymond James | reiterate | Outperform → Outperform | $10 | 54% |
| Apr 17, 2025 | Goldman Sachs | maintain | Buy → Buy | $14 | 54% |
| Apr 9, 2025 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Apr 1, 2025 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $20 | 55% |
| Mar 12, 2025 | Piper Sandler | upgrade | Neutral → Overweight | $12.5 | 54% |
| Mar 4, 2025 | Piper Sandler | maintain | Neutral → Neutral | $11.5 | 54% |
| Mar 3, 2025 | B of A Securities | maintain | Underperform → Underperform | $11 | 53% |
| Feb 25, 2025 | Raymond James | reiterate | Outperform → Outperform | $19 | 54% |
| Feb 25, 2025 | UBS | maintain | Neutral → Neutral | $16 | 54% |
| Feb 12, 2025 | Craig-Hallum | initiate | — → Buy | $29 | 54% |
| Jan 30, 2025 | Piper Sandler | maintain | Neutral → Neutral | $14 | 54% |
| Jan 28, 2025 | Goldman Sachs | maintain | Buy → Buy | $18 | 54% |
| Jan 16, 2025 | Stephens & Co. | reiterate | Equal-Weight → Equal-Weight | $20 | 54% |
| Dec 13, 2024 | B of A Securities | maintain | Underperform → Underperform | $13 | 53% |
| Dec 10, 2024 | UBS | initiate | — → Neutral | $18 | 54% |
| Dec 9, 2024 | Leerink Partners | downgrade | Outperform → Market Perform | $21 | 51% |
| Nov 18, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $21 | 54% |
| Nov 11, 2024 | Piper Sandler | maintain | Neutral → Neutral | $24 | 54% |
| Sep 19, 2024 | Morgan Stanley | initiate | — → Equal-Weight | $32 | 54% |
| Aug 27, 2024 | Wells Fargo | initiate | — → Overweight | $35 | 54% |
| Aug 13, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $34 | 55% |
| Aug 13, 2024 | Piper Sandler | maintain | Neutral → Neutral | $30 | 54% |
| Aug 7, 2024 | TD Cowen | maintain | Hold → Hold | $30 | 54% |
| Aug 7, 2024 | JP Morgan | maintain | Underweight → Underweight | $20 | 55% |
| Jun 27, 2024 | Scotiabank | initiate | — → Sector Outperform | $29 | 55% |
| May 13, 2024 | Piper Sandler | maintain | Neutral → Neutral | $28 | 54% |
| May 8, 2024 | Leerink Partners | upgrade | Market Perform → Outperform | $35 | 51% |
| Jan 30, 2024 | Goldman Sachs | maintain | Buy → Buy | $31 | 54% |
| Jan 29, 2024 | Goldman Sachs | maintain | Buy → Buy | $31 | 54% |
| Dec 21, 2023 | Piper Sandler | initiate | — → Neutral | $23 | 54% |
Price Target Trend
May 14, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days